| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |